Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peripherally induced resiniferatoxin analgesia.

John K Neubert1, Laszlo Karai, Jae H Jun

  • 1Pain and Neurosensory Mechanisms Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA. jneubert@dir.nidcr.nih.gov.2

Pain
|July 12, 2003
PubMed
Summary

Resiniferatoxin (RTX) selectively blocks pain pathways by targeting vanilloid-1 receptors (VR1) on nerve endings. This offers a promising, reversible method for intermediate-term pain management without motor impairment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter to the Editor regarding, "A prospective single arm study of salivary cortisol changes in muscular temporomandibular disorders patients following computer-guided occlusal adjustments".

The Journal of prosthetic dentistry·2026
Same author

Spontaneously hypertensive rats exhibit reduced facial pain sensitivity with altered electrophysiology and transcriptomics in the trigeminal ganglia.

The journal of pain·2026
Same author

Selective opioid-sparing effects of cannabidiol on opioid analgesia in rats.

The journal of pain·2026
Same author

Experimental Evaluation of the Mechanical Healing Performance of Precast Concrete Incorporating Hybrid Capsules Under Load Reapplication for Smart Construction Material.

Materials (Basel, Switzerland)·2026
Same author

Painful cutaneous nodules with a history of uterine fibroids.

JAAD case reports·2026
Same author

Epidermodysplasia verruciformis successfully treated with cimetidine.

JAAD case reports·2026

Area of Science:

  • Pharmacology
  • Neuroscience
  • Pain Research

Background:

  • Selective blockade of nociceptive pathways is a key strategy in pain management.
  • Primary afferent nociceptive nerve terminals are potential targets for therapeutic intervention.

Purpose of the Study:

  • To investigate the efficacy of resiniferatoxin (RTX) in selectively blocking nociceptive pathways.
  • To assess the potential of RTX for intermediate-duration pain control through peripheral C-fiber inactivation.

Main Methods:

  • RTX was administered to the hindpaw of subjects, and heat hyperalgesia and mechanical allodynia were assessed.
  • Dose-response effects of RTX on pain behaviors were evaluated at acute and chronic time points.
  • Thermal nociception, motor function, and spinal c-Fos induction were measured post-injection.

Related Experiment Videos

Main Results:

  • RTX application led to a reversible attenuation of nociceptive transmission.
  • Thermal nociception was decreased in a concentration-dependent manner for up to 21 days.
  • RTX blocked inflammation-induced hyperalgesia and spinal c-Fos induction without impairing motor function.

Conclusions:

  • RTX effectively and selectively inactivates peripheral C-fibers, offering intermediate-duration pain control.
  • The findings demonstrate the therapeutic potential of RTX for managing heat and inflammatory pain.
  • Reversible peripheral C-fiber inactivation represents a viable mechanism-based approach for pain management.